Cargando…

Long-term nifekalant use in a patient with dilated cardiomyopathy and recurrent ventricular tachycardia

The potential utility of nifekalant, a new Class III antiarrhythmic drug, to offer long-term protection against ventricular arrhythmia has been investigated in this case report. A 44-year-old male patient with dilated cardiomyopathy complicated with heart failure and persistent ventricular tachycard...

Descripción completa

Detalles Bibliográficos
Autores principales: Xiao, Hongyan, Chen, Qitong, Tao, Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9620144/
https://www.ncbi.nlm.nih.gov/pubmed/36300319
http://dx.doi.org/10.1177/03000605221133704

Ejemplares similares